← Leaderboards
Thomas J Martin
Wake Forest University Health Sciences
$9,521,616
Attributed
$12,143,119
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,307,841 · 13
By mechanism
P01$12,007,991 · 7
R01$6,474,325 · 4
R21$825,525 · 2
Top collaborators
- Sara R Jones5 shared
- James C Eisenach4 shared
- E. Alfonso Romero-Sandoval4 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Daeyeol Lee$17,391,559
- E. Alfonso Romero-Sandoval$4,456,103
- Matthew Banks$4,322,168
- Christopher Michael Peters$4,476,807
- Patricia E Gallagher$2,799,578
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainChronic PainAnimalsRattusRecoveryBehaviorOperative Surgical ProceduresBrainChronicIn VivoBehavioralRodentPre-ClinicalInjuryAnalgesicsDesignAcute PainPain ManagementNerve InjurySignal TransductionAddictionDoseNeuronsPeripheral
Grant awards (43)
Oxytocin: a pain disease-modifying agent in the nervous system after injury$1,804,300
P01 · FY2025 · NS · contact PI
Cell-directed gene therapy for pain recovery after surgery and inflammation$447,545
R01 · FY2025 · NS
Central oxytocin mechanisms of pain recovery following nerve injury$216,660
P01 · FY2025 · NS · contact PI
Administrative Core$126,169
P01 · FY2025 · NS · contact PI
Oxytocin: a pain disease-modifying agent in the nervous system after injury$1,620,081
P01 · FY2024 · NS · contact PI
Cell-directed gene therapy for pain recovery after surgery and inflammation$437,659
R01 · FY2024 · NS
Central oxytocin mechanisms of pain recovery following nerve injury$231,745
P01 · FY2024 · NS · contact PI
Administrative Core$170,719
P01 · FY2024 · NS · contact PI
Oxytocin: a pain disease-modifying agent in the nervous system after injury$1,742,343
P01 · FY2023 · NS · contact PI
Biased Kappa Opioid Agonists as Non-addictive Analgesics$722,715
R01 · FY2023 · DA · contact PI
Cell-directed gene therapy for pain recovery after surgery and inflammation$458,950
R01 · FY2023 · NS
Central oxytocin mechanisms of pain recovery following nerve injury$294,445
P01 · FY2023 · NS · contact PI
Administrative Core$148,954
P01 · FY2023 · NS · contact PI
Oxytocin: a pain disease-modifying agent in the nervous system after injury$1,997,998
P01 · FY2022 · NS · contact PI
Biased Kappa Opioid Agonists as Non-addictive Analgesics$734,627
R01 · FY2022 · DA · contact PI
Cell-directed gene therapy for pain recovery after surgery and inflammation$465,287
R01 · FY2022 · NS
Administrative Core$333,000
P01 · FY2022 · NS · contact PI
Central oxytocin mechanisms of pain recovery following nerve injury$333,000
P01 · FY2022 · NS · contact PI
Biased Kappa Opioid Agonists as Non-addictive Analgesics$741,673
R01 · FY2021 · DA · contact PI
Biased Kappa Opioid Agonists as Non-addictive Analgesics$755,423
R01 · FY2020 · DA · contact PI
Animal Core$326,277
P01 · FY2020 · GM · contact PI
Cognitive Disability Induced by Surgical Pain and Affective Distress: Role of Attention and Fear Related Circuitry$174,140
P01 · FY2020 · GM · contact PI
Biased Kappa Opioid Agonists as Non-addictive Analgesics$479,128
R01 · FY2019 · DA · contact PI
Animal Core$344,460
P01 · FY2019 · GM · contact PI
Cognitive Disability Induced by Surgical Pain and Affective Distress: Role of Attention and Fear Related Circuitry$174,140
P01 · FY2019 · GM · contact PI
Animal Core$310,015
P01 · FY2018 · GM · contact PI
Cognitive Disability Induced by Surgical Pain and Affective Distress: Role of Attention and Fear Related Circuitry$156,725
P01 · FY2018 · GM · contact PI
Animal Core$343,757
P01 · FY2017 · GM · contact PI
Cognitive Disability Induced by Surgical Pain and Affective Distress: Role of Attention and Fear Related Circuitry$174,141
P01 · FY2017 · GM · contact PI
Animal Core$344,460
P01 · FY2016 · GM · contact PI
Cognitive Disability Induced by Surgical Pain and Affective Distress: Role of Attention and Fear Related Circuitry$228,140
P01 · FY2016 · GM · contact PI
The Monogamous Prairie Vole: A Model for the Study of Social Behavior and Pain$193,750
R21 · FY2015 · NS · contact PI
The Monogamous Prairie Vole: A Model for the Study of Social Behavior and Pain$231,250
R21 · FY2014 · NS · contact PI
Behavioral effects of deep brain stimulation in rats with chronic pain$178,525
R21 · FY2013 · NS · contact PI
Behavioral effects of deep brain stimulation in rats with chronic pain$222,000
R21 · FY2012 · NS · contact PI
Role of the Amygdala in Opioid Self-administration in Rats with Chronic Pain.$215,069
R01 · FY2009 · DA · contact PI
Role of the Amygdala in Opioid Self-administration in Rats with Chronic Pain.$215,069
R01 · FY2008 · DA · contact PI
Role of the Amygdala in Opioid Self-administration in Rats with Chronic Pain.$219,459
R01 · FY2007 · DA · contact PI
Role of the Amygdala in Opioid Self-administration in Rats with Chronic Pain.$226,013
R01 · FY2006 · DA · contact PI
Core--Animal and general research services$206,161
P01 · FY2002 · NS
Chronic opioid self administration in the presence of neuropathic pain$206,161
P01 · FY2002 · NS
OPIOID SELF ADMINISTRATION IN CHRONIC PAIN$180,603
R01 · FY2001 · NS
OPIOID SELF ADMINISTRATION IN CHRONIC PAIN$175,105
R01 · FY2000 · NS